Search
Precision BioSciences Inc
DTILAdd to Watchlist
6.990USD
-0.010-0.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
180.36MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Precision BioSciences Inc is 9.00, ranking 16 out of 385 in the Biotechnology & Medical Research industry. The average price target is 25.50, with a high of 60.00 and a low of 19.00.
Analyst Rating
Based on
5
analysts
Strong Buy
Current Rating
29.600
Target Price
+329.61%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Precision BioSciences Inc
DTIL
5
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Precision BioSciences Inc's expected revenue for the next quarter?
Precision BioSciences Inc's expected revenue is 1.12M.
What is Precision BioSciences Inc's price target?
Analysts forecast that Precision BioSciences Inc's price target is USD 25.50, with the highest forecast at USD 60.00 and the lowest forecast at USD 19.00.
How have Precision BioSciences IncDTIL's recent earnings per share performed?
The market expectation was USD -0.75, while Precision BioSciences IncDTIL's earnings per share (EPS) for the previous quarter was USD 1.05. EPS for the next quarter is expected at USD -0.79.
What is the analyst rating for Precision BioSciences Inc?
Based on the ratings of Precision BioSciences Inc's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.